Qualigen to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
08 sept. 2021 07h30 HE
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Sept. 08, 2021 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN), a biotechnology company focused on developing treatments for adult and pediatric cancers with...
Conformis, Inc. to Participate in Upcoming Investor Conferences
07 sept. 2021 17h00 HE
|
Conformis, Inc.
BILLERICA, Mass., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), an orthopedic medical device company that features a range of personalized knee and hip replacement products,...
Vir Biotechnology to Participate in the H.C. Wainwright 23rd Annual Global Investment Conference
07 sept. 2021 16h05 HE
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Howard Horn, chief financial officer, is scheduled to present at the H.C. Wainwright 23rd...
Innovative Payment Solutions to Present at the H.C. Wainwright 23rd Annual Global Investment Virtual Conference
07 sept. 2021 09h25 HE
|
Innovative Payment Solutions, Inc.
CARMEL, CA, Sept. 07, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire – Innovative Payment Solutions, Inc. (OTCQB: IPSI) (“Innovative” or the “Company”), a California-based fintech company focused on...
Novan to Present at H.C. Wainwright 23rd Annual Global Investment Conference
07 sept. 2021 09h00 HE
|
Novan, Inc.
DURHAM, N.C., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of Novan,...
INVECTYS INC. TO PARTICIPATE IN THE 2021 H.C. WAINWRIGHT 23rd ANNUAL GLOBAL INVESTMENT CONFERENCE SEPTEMBER 13-15, 2021
07 sept. 2021 09h00 HE
|
Invectys, Inc.
Houston, Texas, USA, Sept. 07, 2021 (GLOBE NEWSWIRE) -- Invectys Inc. a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development of a new generation of products...
ObsEva to Present at the H.C. Wainwright 23rd Annual Global Investment Conference
07 sept. 2021 01h00 HE
|
ObsEva SA
GENEVA, Switzerland September 7, 2021 – ObsEva SA (NASDAQ: OBSV; SIX: OBSN), a biopharmaceutical company developing and commercializing novel therapies to improve women’s reproductive health, today...
SOCIAL LIFE NETWORK ANNOUNCES PARTICIPATION AT THE H.C. Wainwright 23rd Annual Global Investment Conference
03 sept. 2021 14h22 HE
|
Social Life Network, Inc.
LOS ANGELES, CA, Sept. 03, 2021 (GLOBE NEWSWIRE) -- Social Life Network, Inc. (OTC: WDLF) today announced it will be featured as a presenting company at the H.C. Wainwright 23rd Annual Global...
Protagenic Therapeutics to Present at the H.C. Wainwright Psychedelics in Psychiatry and Beyond Virtual Conference on June 17th
16 juin 2021 09h15 HE
|
Protagenic Therapeutics, Inc.
NEW YORK , June 16, 2021 (GLOBE NEWSWIRE) -- Protagenic Therapeutics, Inc. (Nasdaq: PTIX) a bioharmaceutical company focused on developing drug product candidates to treat stress-related neurologic...
Novan to Present at the H.C. Wainwright Global Life Sciences Conference
05 mars 2021 09h00 HE
|
Novan, Inc.
MORRISVILLE, N.C., March 05, 2021 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that Paula Brown Stafford, President and Chief Executive Officer of...